SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-208768
Filing Date
2021-07-06
Accepted
2021-07-06 16:31:06
Documents
12
Period of Report
2021-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d164077d8k.htm   iXBRL 8-K 22277
  Complete submission text file 0001193125-21-208768.txt   133708

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ck0001175680-20210630.xsd EX-101.SCH 2939
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001175680-20210630_lab.xml EX-101.LAB 16083
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001175680-20210630_pre.xml EX-101.PRE 10144
5 EXTRACTED XBRL INSTANCE DOCUMENT d164077d8k_htm.xml XML 3010
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 211074502
SIC: 2834 Pharmaceutical Preparations